
August 2003 Cover
|
 |
Strains of HIV largely limited to West Africa appear to have first infected humans in the 1940s, and the current epidemic involving these strains may have originated in 1955-1970 as a result of war, researchers said last month. The current report focuses on HIV-2, which is less
readily transmitted than HIV-1 and appears slower to progress to AIDS. Although HIV-1 infection has grown into a worldwide epidemic, HIV-2 has remained largely confined to West Africa, where it infects approximately 1 percent of the population. HIV-2 appears to have its predecessor
in a strain of simian immunodeficiency virus present in sooty mangabeys.
By comparing HIV-2 samples taken from people with SIV samples taken from sooty mangabeys and other primates that acquired SIV from sooty mangabeys, researchers estimate that the two subtypes of HIV-2 that became epidemics first infected humans around
1940-1945. Study authors said the jump of HIV-2 from sooty mangabeys to humans may have been a result of bushmeat slaughtering or hunting-- the same process that may have enabled HIV-1 to infect humans.
Researchers also discovered evidence suggesting that Guinea- Bissau, the presumed site of origin of HIV-2, experienced a significant increase in new HIV-2 infections in 1955-1970. And that epidemic continues today, Vandamme said. The African region experienced a war
of independence against the Portuguese in 1963- 1974. The fact that the dramatic spread of HIV-2 in the region coincided with this event suggests that war may have encouraged an increase in infections in the region, Vandamme and colleagues said.
War may have spawned a regional HIV-2 epidemic by increasing the number of people who received unsterile injections in hospitals, the authors suggested. Reports from the region note that army-trained doctors started campaigns to inoculate residents of
Guinea-Bissau. Indeed, the first reported cases of HIV-2 in Europe occurred among Portuguese soldiers returned from the independence war, the authors wrote.
Editor's Note: from Reuters Health
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|